
2026-02-27

Introduction
Polydeoxyribonucleotide (PDRN) is a functional polymer of short DNA fragments increasingly used as an active raw material in wound-repair therapies, injectables and premium skincare formulas. For manufacturers and procurement teams, the single most important technical attribute of PDRN is molecular-weight distribution — the precise sizes and proportions of DNA fragments in a lot directly affect tissue interaction, product stability and regulatory fit. This article presents a supplier-oriented guide to accepted molecular-weight bands for different applications, practical laboratory methods for verification, essential quality controls, and the exact procurement questions procurement and R&D teams should ask before placing a bulk order.
PDRN is a purified preparation of short, linear deoxyribonucleotide fragments. Rather than a single molecule, PDRN is a mixture whose bioactivity arises from the relative abundance of different fragment sizes. Fragment length determines how a molecule diffuses through tissue, how long it persists, and which cellular mechanisms it engages — therefore, not all PDRN powders are interchangeable. A supplier that controls fragment distribution and documents it clearly reduces formulation risk for manufacturers.
The ranges below are practical specifications manufacturers commonly request. Use them as starting points when negotiating product specs or asking for certified samples.
| Application Type | Typical MW Range (kDa) | Why this range |
|---|---|---|
| Injectable / Medical | 200 – 1500 kDa | Sustained activity under tissue; controlled degradation profile |
| Topical / Cosmetic | 60 – 200 kDa | Better skin penetration and low irritation risk |
| Research / Reference Standard | 50 – 1500 kDa (full profile) | Full-spectrum for in-lab comparison and assay calibration |
Note: these bands are target ranges. Buyers should request the actual distribution curve (e.g., histogram or chromatogram) rather than a single “average” value.
Reliable vendors supply orthogonal test data. Common and accepted methods include:
Size-exclusion chromatography (SEC / GPC) — primary method to obtain a molecular-weight distribution curve and calculate Mn/Mw and polydispersity (PDI).
HPLC with UV detection — used to confirm chemical purity and quantify nucleic acid content.
Mass spectrometry (e.g., MALDI-TOF) — useful for resolving peak patterns of smaller oligomers and confirming mass ranges.
UV spectrophotometry (A260/A280 ratio) — quick check for nucleic acid purity and protein contamination.
Endotoxin (LAL) and sterility testing — critical for injectable grades.
What to request from suppliers: raw chromatograms (GPC traces), Mw and Mn values, PDI, test methods and instrument models, and full batch COA.
When your product will be used in manufacturing medical or injectable products, insist on these documented controls:
COA with MW distribution (GPC chromatogram attached)
DNA purity percentage (HPLC result)
Endotoxin limit (EU/mg) and LAL test report
Sterility test result (for sterile formats)
Heavy metals (ICP-MS report for Pb, Hg, As, Cd)
Microbial limits (bioburden)
Stability data (accelerated and real-time)
Production standards (cGMP certificate, facility audit evidence)
Traceability (raw material origin, lot numbers and chain of custody)
Suppliers who include method SOPs and instrument calibration records demonstrate higher audit readiness.
What is the exact molecular-weight distribution for the batch (provide GPC chromatogram)?
Which analytical methods and instruments were used to measure MW and purity?
Can you provide COA, endotoxin report, heavy metals, and stability data for the lot?
Is production performed under GMP and is there third-party certification?
What is the formulation format (sterile powder, sterile solution) and recommended storage?
Do you offer technical support, formulation guidance, and sample testing before purchase?
What are your minimum order quantities, lead times, and shipping conditions for bulk lots?
Keep these questions as a script when vetting suppliers — demand documents first, then samples.
Start with a certified sample and run your in-house SEC/HPLC to confirm supplier data.
Document acceptance criteria (e.g., acceptable PDI, endotoxin limit) in purchasing contracts.
Ask about lot-to-lot variability and request a history of past batch COAs.
Consider formulation compatibility (pH, excipients) — fragment stability can be sensitive to formulation conditions.
If you need certified, bulk PDRN with complete molecular-weight documentation, request a technical packet and sample today. Our packets include GPC chromatograms, HPLC purity reports, endotoxin and heavy-metal analyses, and GMP certification for injectable grades.
Request sample & COA → [Get a quote / Request sample] (suggested anchor: Request a PDRN sample & COA)
Technical inquiry → [Contact our technical team] (suggested anchor: Speak to a PDRN specialist)
Product page: “PDRN product specifications” → anchor text: PDRN product page
Quality / Compliance page: “GMP & COA details” → anchor text: GMP & COA
Formulation support page: “Formulation and stability guidance” → anchor text: Formulation support
Case studies: “Clinical & cosmetic use cases” → anchor text: PDRN case studies
Add these internal links near relevant paragraphs (e.g., after the QC paragraph link to GMP & COA).
Q1: What fragment sizes are best for topical PDRN?
A1: Topical formulations commonly use mid-range fragments (roughly 60–200 kDa) to balance skin penetration and stability.
Q2: How should I verify a supplier’s molecular-weight claim?
A2: Request the GPC/SEC chromatogram and COA; confirm with an independent in-house or contract lab if needed.
Q3: What tests are non-negotiable for injectable PDRN?
A3: Endotoxin (LAL), sterility, heavy metals, and documented GMP production are mandatory for injectable use.
Q4: Can I request custom molecular-weight fractions?
A4: Many manufacturers can fractionate or supply narrower MW bands on request; discuss MOQ and lead time.